The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer

ConclusionsCompared to previous years, the number of esophagogastric cancer diagnoses decreased in the first 2  months of the COVID-19 pandemic, while an increased percentage of patients was diagnosed with incurable disease. Both in the curative and palliative setting, patients were less likely to be treated with a surgical resection.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research